The National Proton Therapy Center of Portugal will be equipped with two IBA Proteus®ONE solutions
Louvain-La-Neuve, Belgium, June 30, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today the entering into effect of a contract with Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto), for the installation of two Proteus®ONE1 compact proton therapy solutions at the IPO-Porto facilities in Porto, Portugal. The two Proteus®ONE system
Louvain-La-Neuve, Belgium, June 30, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today the entering into effect of a contract with Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto), for the installation of two Proteus®ONE1 compact proton therapy solutions at the IPO-Porto facilities in Porto, Portugal. The two Proteus®ONE systems will be the first proton therapy systems in the country and will serve as the National Proton Therapy Center of Portugal.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.